Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround

LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk arsenic it rode the roar of its obesity and diabetes medications to go 1 of the biggest players successful pharma, lone to spot that occurrence stall successful caller months, is stepping down arsenic CEO, the institution said Friday.
Jørgensen, who’s worked…

This communicative appeared connected statnews.com, 2025-05-16 20:04:01.056000.